Add to ORKGIfosfamide is an alkylating chemotherapeutic agent that is a structural analog of cyclophosphamide. Ifosfamide has activity against a wide range of both solid and hematological malignancies and i
Ifosfamide is used in the treatment of sarcomas and other tumors. It sometimes provokes encephalopat...
Ifosfamide (IF) and cyclophosphamide (CTX) are chemotherapeutic agents frequently used in the treatm...
Glioblastoma multiforme is the most common malignant primary brain tumor in adults. Despite new trea...
Ifosfamide, an alkylating agent used in cancer treatments, can cause neurotoxicity. The clinical pre...
Ifosfamide is a well known prodrug for cancer treatment with cytochrome P450 metabolism. It is assoc...
Ifosfamide is an alkylating agent that is widely used in the treatment of various neoplasms, such as...
Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neuro...
L ifosfamide, (IFO) est un agent bisalkylant cytotoxique. L IFO est largement utilisé, tant en onco-...
SummaryObjectiveTo report two cases of recurrent uterine sarcoma that developed ifosfamide-induced e...
The clinical use of the alkylating oxazaphosphorine ifosfamide is hampered by a potentially severe e...
L’ifosfamide (IFO) est un alkylant de l’ADN de la famille des Oxazaphosphorines, largement utilisé d...
Ifosfamide (IFO) is an alkylating agent of the DNA from Oxazaphosphorine family, widely used in vari...
A total of 55 patients were treated with ifosfamide on two different treatment schedules. Twenty-fou...
Phase II studies conducted in Europe and the USA on pediatric solid tumors have shown that ifosfamid...
Therapeutic value of the alkylating agent ifosfamide has been limited by major side effects includin...
Ifosfamide is used in the treatment of sarcomas and other tumors. It sometimes provokes encephalopat...
Ifosfamide (IF) and cyclophosphamide (CTX) are chemotherapeutic agents frequently used in the treatm...
Glioblastoma multiforme is the most common malignant primary brain tumor in adults. Despite new trea...
Ifosfamide, an alkylating agent used in cancer treatments, can cause neurotoxicity. The clinical pre...
Ifosfamide is a well known prodrug for cancer treatment with cytochrome P450 metabolism. It is assoc...
Ifosfamide is an alkylating agent that is widely used in the treatment of various neoplasms, such as...
Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neuro...
L ifosfamide, (IFO) est un agent bisalkylant cytotoxique. L IFO est largement utilisé, tant en onco-...
SummaryObjectiveTo report two cases of recurrent uterine sarcoma that developed ifosfamide-induced e...
The clinical use of the alkylating oxazaphosphorine ifosfamide is hampered by a potentially severe e...
L’ifosfamide (IFO) est un alkylant de l’ADN de la famille des Oxazaphosphorines, largement utilisé d...
Ifosfamide (IFO) is an alkylating agent of the DNA from Oxazaphosphorine family, widely used in vari...
A total of 55 patients were treated with ifosfamide on two different treatment schedules. Twenty-fou...
Phase II studies conducted in Europe and the USA on pediatric solid tumors have shown that ifosfamid...
Therapeutic value of the alkylating agent ifosfamide has been limited by major side effects includin...
Ifosfamide is used in the treatment of sarcomas and other tumors. It sometimes provokes encephalopat...
Ifosfamide (IF) and cyclophosphamide (CTX) are chemotherapeutic agents frequently used in the treatm...
Glioblastoma multiforme is the most common malignant primary brain tumor in adults. Despite new trea...